Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles - 2Key Little Things That Advantage Old People
- 3Surge of off‑lease electric vehicles expected to drive down used EV prices
- 47 Methods for further developing Rest Quality
- 5The Significance of Prenuptial Arrangements in Separation Procedures
- Ford Is Using a Chinese-Built Van to Fight Europe’s EV Price War
- The Extraordinary Excursion of Dental Embed Innovation
- The most effective method to Succeed in Your Profession with a Web based Advertising Degree
- Inflammatory Merz remarks on migrants' violence against women slammed
- Reports: Germany plans expansion of foreign intelligence powers
- Avoid This Common Mistake When Planning Sightseeing Activities For Your Trip To Italy
- Keep It Cool: Uncovering Famous Fridge Brands for Each Home
- German politician urges more face-to-face interaction in digital age
- The Specialty of Compromise: Examples from Reality
